BackCitius Oncology Overview

Citius Oncology Total Liabilities

Track Citius Oncology's total liabilities ($65M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$65.43M
↑ 17.27% YoYΔ $9.63M vs prior year quarter

Peer average

Loading

Citius Oncology Total Liabilities History

Loading

Citius Oncology vs. peers: Total Liabilities Comparison

Loading

Citius Oncology Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Citius Oncology (CTOR) FAQ

Citius Oncology (CTOR) currently reports a total liabilities of $65M as of March 2026. That compares with $56M in the prior-year period — up 17.3% year over year. Use the charts on this page to explore Citius Oncology's total liabilities history and peer comparisons.

Citius Oncology's total liabilities increased from $56M to $65M — a 17.3% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Citius Oncology reported $65M in total liabilities as of March 2026. That compares with $56M in the prior-year period — up 17.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $65M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Citius Oncology, and consider following CTOR for alerts when major investors trade the stock.